Why the last mile in pharmacy stays local
Distribution consolidates; retail mostly doesn't. The reason sits in human behaviour at the counter — and it decides where the real value pools.
It's a natural assumption: if distribution is going to consolidate into a few large operators, surely retail will follow — a handful of national pharmacy chains swallowing the neighbourhood shops. It's a clean story. It's also, in India, mostly wrong.
Two layers, two different fates
The supply chain has two layers that look adjacent but behave nothing alike. Distribution is invisible to the patient and rewards scale ruthlessly. Retail is the opposite — it lives or dies on trust, proximity, and the person behind the counter.
The middle consolidates; the ends stay broad. Value pools where the network narrows — the rails — not at the counter. Illustrative.
Why the counter resists consolidation
Stand in a neighbourhood pharmacy for an hour and the reason becomes obvious. The pharmacist knows which customer is diabetic, which mother is buying for a sick child, which elderly regular needs a substitute explained slowly. People buy medicine from someone they trust, close to home, often in a hurry. That relationship doesn't get more efficient at national scale — it gets worse.
Chains can win pockets — airports, malls, certain metros. But the long tail of Indian pharmacy is woven into its streets, and that texture is a feature of the market, not a bug waiting to be fixed.
Where that leaves the value
If retail stays broad and local, then the value of consolidation pools in the layer that does reward scale: the rails underneath. Whoever owns those rails serves every counter without needing to own a single one of them — supplying inventory, financing working capital, and increasingly providing the software the counter runs on.
This is why our thesis is precise about where to build. We're not trying to become India's pharmacy chain. We're building the infrastructure every pharmacy depends on, while leaving the counter exactly where it belongs — local, trusted, and human.
The Founder's Office is our monthly read on Indian pharma — the macro forces, the structural shifts, and what they mean for everyone building in this market.